AARTIPHARM.NSAARTIPHARM.NSNSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+12.4%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+12.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
20253.42+43.5%
20242.38+71.6%
20231.39-42.3%
20222.41-
20210.00-
20200.00-